Contacts

Howard Palmer

Partner

Read More

Elinor Picton

Senior Counsel

Read More
Contacts

Howard Palmer

Partner

Read More

Elinor Picton

Senior Counsel

Read More

4 April 2023

Advising Dawn Capital on US$129m Series E round for Quantexa

We have advised longstanding client Dawn Capital on its latest investment as part of a $129 million Series E fundraising for Quantexa at a valuation of $1.8 billion. The investment is one of the largest of the year so far for a UK-based firm and marks the first British unicorn of 2023.

This latest deal for the early-stage VC fund expands its investment into the data and analytics software company and follows our previous advice to Dawn Capital on Quantexa's $20 million Series B, $64.7 million Series C, and $153 million Series D funding.

Dawn Capital, Europe's largest specialist B2B software investor, backs companies at series A and B and continues to fund the best performing through growth rounds to exit. We have advised Dawn Capital on other numerous transactions over the last 10 years including investments in Dataiku, Eigen Technologies, Ably, Firebolt Analytics, Tink, and Copper Technologies.

Quantexa specialises in contextual decision intelligence, using data and machine learning to help businesses make better decisions across multiple areas, including financial crime compliance, KYC, customer intelligence, fraud and credit risk.

Commenting on the transaction, Partner Howard Palmer said: "This latest investment in Quantexa demonstrates Dawn Capital's commitment to innovation, and the support and development of its portfolio of companies. We're seeing more strategic investment in the technology sector overall, something we need to continue in the current market to preserve our most ground-breaking technology companies and their innovations."

Dawn Capital was advised by partner Howard Palmer and senior associate Elinor Picton.

This round was led by GIC, with participation from Dawn Capital and other existing investors including Warburg Pincus, Albion VC, BNY Mellon, Evolution Equity Partners, HSBC, ABN AMRO Ventures and British Patient Capital.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Corporate/M&A & capital markets

Advising GeoPura on its £56 million investment round to accelerate UK's green hydrogen expansion

22 February 2024

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Advising Vortexa on its $34 million Series C funding

9 January 2024

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Advising Mitel on its transaction to acquire Unify from Atos

2 October 2023

by multiple authors

Click here to find out more